Infectious disease patent intelligence

US 7217541

Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections

The United States of America as represented by the Secretary of the Army · Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7201902

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7201911

Cloned genomes of infectious hepatitis C viruses and uses thereof

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7192593

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7183268

2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7183095

Cell culture system for synthesis of infectious hepatitis C virus

The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7176208

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7173007

Therapy for microbial infections

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7157473

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7157495

Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7153880

Substituted diphenyl heterocycles useful for treating HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7151087

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

The United States of America as represented by the Department of Health and Human Resources · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7148323

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7144875

Methods of treating fungal infections using lupeol

Regents of the University of Minnesota · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7135324

Viral recombinases, related articles, and methods of use thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132271

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132102

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7132454

HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7129342

Infectious cDNA clone of GB virus B and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7125845

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7115590

Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents

University College Cardiff Consultants Limited · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7115262

Chimeric protein for prevention and treatment of HIV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094413

Combined therapy for treatment of HIV infection

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084266

Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7078507

Synthetic genes for malarial proteins and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7078037

Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7070790

Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7067620

Antibacterial agents

Theravance, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052696

Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052904

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052676

Methods for inhibition of HIV replication using a small molecule inhibitor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7049127

Method of producing infectious reovirus

ONCOLYTICS BIOTECH INC. · Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7045284

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7045336

Bacterial delivery system

The United States of America as represented by the Secretary of the Army · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7037534

Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds

Aphios Corporation · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7025963

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7026155

Method of reducing bacterial proliferation

The Regents of the University of California · Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7019135

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7018636

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7015212

Thiazepine inhibitors of HIV-1 integrase

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7001718

Method of inhibiting pathogenicity of infectious agents

THE ARIZONA BOARD OF REGENTS · Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)